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Summary
Cell-penetrating peptides have been widely used to
improve cellular delivery of a variety of proteins and
antisense agents. However, recent studies indicate that
such cationic peptides are predominantly entering cells
via an endosomal pathway. We now show that the
nuclear antisense effect in HeLa cells of a variety of
peptide nucleic acid (PNA) peptide conjugates is sig-
nificantly enhanced by addition of 6 mM Ca2+ (as well
as by the lysosomotrophic agent chloroquine). In par-
ticular, the antisense activities of Tat(48-60) and hep-
taarginine-conjugated PNAs were increased 44-fold
and 8.5-fold, respectively. Evidence is presented that
the mechanism involves endosomal release. The pres-
ent results show that Ca2+ can be used as an effective
enhancer for in vitro cellular delivery of cationic pep-
tide-conjugated PNA oligomers, and also emphasize
the significance of the endosomal escape route for
such peptides.
Introduction
Peptide nucleic acids (PNA) have long been considered
as promising candidates for the discovery and develop-
ment of gene therapeutic antisense agents, but quick
progress is hampered by suboptimal techniques for cellu-
lar delivery [1, 2]. Several methods are available for de-
livery of PNA oligomers to cells in culture. The techniques
include delivery of PNA/DNA heteroduplexes [3], fatty
acid- [4] or 9-aminoacridine-conjugated PNA via cat-
ionic liposomes [5, 6], and direct delivery of PNAs conju-
gated to a variety of cell-penetrating peptides [7, 8] or
to triphenylphosphonium ligands [9]. Especially, the cell-
penetrating peptide conjugates appear to offer an un-
complicated method for experiments in cell cultures.
Indeed, a number of studies have reported convincing
antisense activity of PNA and morpholino oligomers
conjugated to such peptides [10–13], although rather
high (micromolar) concentrations were required to achieve
the cellular antisense effects. Furthermore, several studies
have demonstrated that delivery using cationic pep-
tides occur via the endosomal/lysosomal compartment
of the cell [7, 10], thereby providing an explanation for
the relatively poor antisense activity of such conjugates
despite apparently effective cellular uptake when ana-
lyzed by fluorescence microscopy. Therefore, improved
methods and/or protocols for cellular delivery of PNA*Correspondence: pen@imbg.ku.dk(and other [antisense] agents) are very much warranted.
In the search for such improved methods, we have syn-
thesized a series of PNA-cationic peptide conjugates
and evaluated their efficiency in an antisense assay.
We employed a sensitive luciferase-based method
using HeLa pLuc705 cells [14]. The antisense mole-
cule—targeting an aberrant splice site within intron
2—can correct mis-splicing and ensure translation of
a functional luciferase protein. Therefore this splicing
correction assay provides a positive readout (of lucifer-
ase activity), effectively avoiding false-positive read-
outs due to cellular toxicity. Furthermore, the assay re-
flects the number of antisense molecules delivered into
the nucleus, where the antisense molecule binds to the
target pre-mRNA to redirect splicing.
Endosomal escape of the antisense agent is most
likely one of the major rate-limiting steps during cellular
delivery via cationic peptides [7, 8, 10, 15], as it is also
for delivery of DNA/polycation complexes. Recently,
Zaitsev et al. [16] showed that transfection of DNA
complexed with histone H1 protein is arrested in endo-
somes/lysosomes, and they demonstrated that addi-
tion of Ca2+ can enhance transfection efficiency, pre-
sumably by facilitating endosomal release. They also
showed that addition of 4–6 mM of Ca2+ enhances
the transfection of several other polycation/DNA com-
plexes, such as HMG1/DNA, polylysine/DNA, and cat-
ionic lipid/DNA [17, 18]. Although the mechanism of the
Ca2+ effect on transfection is not yet fully understood
[16], these results prompted us to test the effect of Ca2+
on the antisense potency of cationic peptide-conju-
gated PNAs.
In this study, we demonstrate that addition of Ca2+ to
the medium dramatically increases the nuclear anti-
sense effect of PNA-peptide conjugates [up to 50-fold
using Tat(48-60) peptide] in HeLa pLuc705 cells in
culture.
Results and Discussion
In order to evaluate the effect (if any) of Ca2+ on the
cellular delivery of PNA-peptide conjugates, a series of
PNA conjugates with a range of cell-penetrating cat-
ionic peptides were synthesized and tested in the
pLuc705 HeLa cell luciferase system (the nomenclature
and the sequences of PNAs are listed in Table 1). In
a preliminary screening, the pLuc705 HeLa cells were
treated with 1 M PNAs with or without addition of 6
mM Ca2+ for 24 hr and subjected to the luciferase assay
(Figure 1A). Treatment with naked PNA resulted in only
a 1.7-fold increase in relative light units (RLUs) relative
to the control (no PNA treatment). Treatment with
(Arg)7-PNA or (Arg)9-PNA resulted in significantly higher
luciferase activity (RLUs) than the control (14-fold and
27-fold, respectively), whereas treatment with (Arg)6-
PNA produced only a 2.5-fold increase of RLU (which
is not significantly different from naked PNA), and the
remaining cationic peptide-conjugated PNAs (NLS-
PNA, [KFF]3-PNA, and Tat-PNA) did not show activity
much higher than that of naked PNA.
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924Table 1. Nomenclature and Sequences of PNA-Peptide Conjugates
Names Sequencea
Naked PNA H-CCT CTT ACC TCA GTT ACA-NH2
(Arg)6-PNA H-RRRRRR-Gly-CCT CTT ACC TCA GTT ACA-NH2
(Arg)7-PNA H-RRRRRRR-Gly-CCT CTT ACC TCA GTT ACA-NH2
(Arg)9-PNA H-RRRRRRRRR-Gly-CCT CTT ACC TCA GTT ACA-NH2
(KFF)3-PNA H-KFFKFFKFFK-eg1-CCT CTT ACC TCA GTT ACA-NH2
NLS-PNA H-PKKKRKV-eg1-CCT CTT ACC TCA GTT ACA- NH2
Tat-PNA H-GRKKRRQRRRPPQ-eg1-CCT CTT ACC TCA GTT ACA-NH2
(Arg)6-PNA-MMb H-RRRRRR-Gly-CCT CTG ACC TCA TTT ACA-NH2
(Arg)9-PNA-MMb H-RRRRRRRRR-Gly-CCT CTG ACC TCA TTT ACA-NH2
Tat-PNA-MMb H-GRKKRRQRRRPPQ-CCT CTG ACC TCA TTT ACA-NH2
(Arg)7-Fl-PNAc H-RRRRRRR-Fl-eg1-CCT CTT ACC TCA GTT ACA-NH2
a The sequences of cell-penetrating peptides are written using the standard one-letter amino acid symbols. The sequences of peptides and
PNAs are written from N-terminal- to C-terminal-end.
b PNA-MM indicates a mismatch PNA sequence, whereas two mismatches are indicated in bold.
c (Arg)7-Fl-PNA had fluorescein (Fl) attached to the -amino group of a lysine residue (20).According to Haberland et al. [17], addition of Ca2+
(4–6 mM) can improve the efficacy of polycation (such
as lysine rich nuclear proteins or polylysine)-mediated
DNA transfections. Therefore, we initially tested the ef-
fect of addition of 6 mM Ca2+ on the antisense activity
of cationic PNA-peptide conjugates. The activity of all
of the PNAs, in particular that of (Arg)7-PNA, (Arg)9-PNA,
and Tat-PNA, was increased in the presence of Ca2+
(5-fold, 2-fold, and 25-fold, respectively, while Ca2+
addition alone did not significantly induce luciferase
activity). These results clearly demonstrate that Ca2+
dramatically enhances the antisense effect of PNAs
conjugated to cationic peptides and that the magnitude
of this effect differs significantly between the various
peptides.
To further characterize the antisense effects of oli-
goarginine-conjugated PNAs, we studied these PNAs,
as well as two corresponding control mismatch PNAs,
more thoroughly in terms of luciferase antisense activa-
tion and cellular toxicity (Figure 1B). Without Ca2+ addi-
tion, treatment with naked PNA or with (Arg)6-PNA at
1 M or 2 M resulted in no significant luciferase acti-
vation compared to the control. In contrast, treatment
with (Arg)7-PNA or (Arg)9-PNA produced a dose-depen-
dent increase of RLUs (13-fold and 29-fold, respec-
tively, at 2 M), whereas the two control mismatch
PNAs, conjugated to hexaarginine or nonaarginine,
were practically inactive in the assay. This polyarginine
length dependency in uptake properties corroborate
the result of previous reports [13, 21]. However, treat-
ment with (Arg)9-PNA decreased cellular viability to
67% at 2 M even without Ca2+ addition. This toxic
effect most likely originates from the 9-mer L-arginine
moiety, because the mismatch PNA conjugated to
nonaarginine exhibited similar toxicity. However, in the
presence of Ca2+, (Arg)7-PNA at 2 M was slightly more
active than (Arg)9-PNA without severely affecting cell
viability (113-fold and 109-fold, respectively, compared
with the control). These results prompted us to study
further the activity of the (Arg)7-PNA in combination
with Ca2+.
In order to optimize the Ca2+ concentration, (Arg)7-
PNA was delivered to the cells in the presence of vari-
ous concentrations of Ca2+ (Figure 2). The (Arg) -PNA
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T7xhibited the highest activity at 6 mM Ca2+. Further-
ore, addition of Ca2+ up to 6 mM did not result in
evere cellular toxicity, neither in the presence or in the
bsence of the PNA. However, addition of Ca2+ greater
han 6 mM lowered the cellular viability (as well as
LU). Therefore, 6 mM Ca2+ appeared optimal and was
sed for further experiments.
Next, we compared naked PNA, (Arg)7-PNA, and Tat-
NA in the presence and absence of 6 mM Ca2+ addi-
ion at various PNA concentrations (0.5–4.0 M) (Figure
A). Ca2+ addition resulted in higher RLU at every PNA
oncentration. However, the effect of Ca2+ is much
ore pronounced for (Arg)7-PNA and, especially, Tat-
NA than for the naked PNA. In fact, the Tat-PNA and
he (Arg)7-PNA exhibited almost equal activity in the
resence of Ca2+ despite the extremely low activity of
he Tat-PNA without Ca2+ addition. The Tat peptide
as been shown to be taken up predominantly via an
ndocytotic pathway [8] through the electrostatic in-
eraction between the polycationic peptide and nega-
ively charged cellular surface components. Thus, the
ramatic effect of Ca2+ on Tat-PNA, but not on naked
NA, might suggest that Ca2+ has an effect on a pro-
ess after cellular uptake, such as endosomal escape.
Increased luciferase activity (measured in RLUs)
hould directly reflect an increased level of corrected
uciferase mRNA (produced by an antisense effect of
NA for mis-splicing correction). RT-PCR analysis was
erformed to obtain a semiquantitative measure of the
evel of correctly spliced luciferase mRNA (Figure 3B).
ithout Ca2+ addition, treatment with the (Arg)7-PNA
id not result in any detectable accumulation of the
orrected form (142 bp) up to 2 M (Figure 3Ba), and
nly 7% correction was seen at 4 M. However, Ca2+
ddition dramatically increased the level of corrected
RNA at every PNA concentration tested, reaching
6% at 4 M (Arg)7-PNA. In addition, we tested Tat-
NA and its mismatch (Tat-PNA-MM) (Figure 3Bb), for
hich the levels of the splicing corrected form were
nly 2% and 1% for Tat-PNA and Tat-PNA-MM, respec-
ively, without Ca2+ addition. Addition of Ca2+ increased
he corrected form to 92% at 2 M Tat-PNA, whereas
nly 2% correction was detected at 2 M Tat-PNA-MM.
his Ca2+-dependent increase of the corrected form by
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925Figure 1. Effect of Ca2+ on the Activity of PNA-Peptide Conjugates
with Different Cationic Peptides
HeLa pLc705 cells were treated with PNsA for 24 hr in the absence
or presence of 6 mM Ca2+. Luciferase activity was measured using
Bright-Glo reagent (Promega) and is presented as relative light
units (RLUs). Each bar represents the mean ± SD of three indepen-
dent experiments.
(A) HeLa pLc705 cells were treated with PNAs (1 M) for 24 hr in
the absence (filled bars) or in the presence of 6 mM Ca2+ (white
bars). The numbers on the bars indicate the fold increase of each
RLU value relative to the control (no PNA, no Ca2+).
(B) Effect of the numbers of arginines on the activity of polyargi-
nine-conjugated PNAs. Polyarginine-conjugated PNA with different
numbers of arginines (number of arginines; six, seven, and nine)
were used. For (Arg)6-PNA and (Arg)9-PNA, PNAs containing two
base mismatches (shown as PNA-MM) were also used as a control.
White bars, PNA at 1 M without Ca2+; cross-hatched bars, PNA
at 2 M without Ca2+; black bars, PNA at 1 M with 6 mM Ca2+;
hatched bars, PNA at 2 M with 6 mM Ca2+. Presented are (Ba)
luciferase activity and (Bb) cellular viability (expressed as relative
cellular viability; the absorbance from non-PNA treated cells was
set as 100%).Figure 2. Effect of Ca2+ Concentration on the Activity of (Arg7)-PNA
HeLa pLuc705 cells were treated with (Arg)7-PNA (1 M) for 24 hr
in the presence of different concentrations of Ca2+. Each data point
represents the mean ± SD from three independent experiments.
(A) Luciferase activity shown as RLUs.
(B) Cellular viability (the absorbance from non-PNA treated cells
without Ca2+ addition was set as 100%).PNAs fully agrees with the results of the luciferase ac-
tivity assay.
Uptake of (Arg)7-PNA was confirmed by confocal
laser scanning microscopy using fluorescein-labeledPNA ([Arg]7-Fl-PNA). The pLuc-HeLa cells were treated
with (Arg)7-Fl-PNA (green fluorescence) for 15 min with
or without Ca2+, washed thoroughly, then chased in the
OPTI-MEM medium for 45 min. The endocytosis marker
transferrin (red fluorescence) was cotransfected with
PNA. Colocalization of green and red fluorescence on
the merged images (Figure 4Ac and 4Af) are seen as
yellow spots. Thus, the marked colocalization of PNA
with transferrin provides compelling evidence that the
PNA predominantly accumulates in the endosomes,
both in the absence as well as in the presence of Ca2+
(Figure 4A). The uptake of (Arg)7-Fl-PNA occurs rela-
tively quickly, as 15 min of incubation with PNA is suffi-
cient for the detection of the discernible green spots
in the cytoplasm (Figure 4Aa) of virtually all cells. This
observation agrees with the results of the polyarginine
peptide transfection studies performed by Thoren et
al. [8].
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926Figure 3. Effect of a 6 mM Concentration Ca2+ on the Activity
of PNAs
HeLa pLuc705 cells were treated with PNAs at the indicated con-
centrations for 24 hr in the absence or presence of 6 mM Ca2+ and
subjected to further analysis.
(A) Naked PNA (filled circle, open circle), (Arg)7-PNA (filled triangle,
open triangle), or Tat-PNA (filled square, open square) were used
at the indicated concentrations for 24 hr in the absence (filled sym-
bols) or presence of 6 mM Ca2+ (open symbols). Luciferase activity
was measured using Bright-Glo reagent (Promega) and is pre-
sented as RLUs. Each data point represents the mean ± SD from
three independent experiments.
(B) RT-PCR analysis of the mis-splicing correction of pre-mRNAs
by PNAs. After transfection of the PNAs, total RNA was extracted
and subjected to RT-PCR analysis. Uncorrected (268 bp) indicates
the fragments without mis-splicing correction, and corrected (142
bp) indicates the mis-splicing corrected mRNA form. Numbers un-
der each lane indicate the relative amount of the corrected form to
the sum of corrected form and uncorrected form. (Ba) Cells were
treated with (Arg)7-PNAs at the indicated concentrations in the ab-
sence or presence of 6 mM Ca2+. (Bb) Cells were treated with Tat-
PNA (2 M) or Tat-PNA-MM (2 M) in the absence or presence of
6 mM Ca2+. Tat-PNA-MM is a mismatch PNA containing two mis-
matches.
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nd Intracellular Distribution
A) Confocal microscopic studies of (Arg)7-Fl-PNA delivery to HeLa
Luc705 cells. Cells were treated with 1 M of the PNA and 20 g/
l transferrin for 15 min with (Ad–Af) and without (Aa–Ac) 6 mM
a2+. Cells were then washed and incubated further in OPTI-MEM
edium for 45 min, and analyzed by confocal microscopy. PNA
green [Aa and Ad]), transferrin (red [Ab and Ae]) and merged
mages ([Ac] and [Af], respectively for [Aa and Ab] and [Ad and Ae])
re shown. Scale bars represent 35 m.
B) Flow cytometric analysis of the (Arg)7-Fl-PNA delivery to HeLa
Luc705 cells. Cells were treated with 1 M of PNA for 4 hr in the
resence or absence of 6 mM Ca2+, and harvested by scraping
trypsin−) or by trypsination (trypsin+). Cells (2000 events) were an-
lyzed using a BD FACSCalibur cytometer, and the fluorescence
ndex was determined by dividing the mean fluorescence of the
NA-treated sample by the mean fluorescence of a non-PNA
reated sample.Clear differences in the intracellular localization of
NA in the absence or presence of Ca2+ are apparent.
n the absence of Ca2+, PNA is seen in vesicles in
he cytoplasm and in the vicinity of the nuclei (Figure
Aa), whereas Ca2+ addition significantly increases the
mount of complexes at the plasma membrane borders
see Figure 4Ad). However, in neither case was distinct
uclear staining observed.
Flow cytometric analysis was performed in an at-
empt to quantify the Ca2+ effect on PNA cellular deliv-
ry (Figure 4B). By collecting cells using the scraping
ethod (Trypsin−), the fluorescence index increased
Ca Enhancement of Antisense PNA-Peptide Conjugates
9273-fold upon Ca2+ treatment. However, the effect of Ca2+
could not be detected when the cells were colleted by
trypsinization (Trypsin+). These results indicate that
Ca2+ treatment increases the interaction between the
PNA and the cellular membrane (as also indicated by
the confocal microscopy data), which may in turn in-
crease (endosome-mediated) PNA internalization.
In order to further elucidate the mechanism of the
Ca2+ effect on PNA-peptide conjugate activity, we
tested the well-known lysosomotropic agent, chlo-
roquine (CQ), which is known to facilitate release of
macromolecules from endosomes [22] (Figure 5). CQ
(15, 30, 60, and 120 M) was added together with the
PNAs (naked PNA, [Arg]7-PNA and Tat-PNA), and the
obtained RLUs were compared with those associated
with Ca2+ addition. Addition of CQ showed a clear
dose-dependent increase in RLUs for both (Arg)7-PNA
and Tat-PNA, but not for naked PNA. Addition of 120
M CQ and 6 mM Ca2+ showed similar enhancement
of the RLUs for both (Arg) -PNA and Tat-PNA withoutFigure 5. Effect of the Chloroquine and 6 mM Ca2+ on the Activity
of PNA
(A) HeLa pLuc705 cells were treated with PNA in the presence of
chloroquine (CQ) (15, 30, 60, and 120 M) or Ca2+ (6 mM) for 24 hr.
Naked PNA, (Arg)7-PNA, and Tat-PNA were used at 1 M. Lucifer-
ase activity is shown as RLUs. Each bar represents the mean ± SD
from three independent experiments.
(B) RT-PCR analysis of the mis-splicing correction of pre-mRNAs
by (Arg)7-PNA in combination with CQ. (Arg)7-PNA (1 M) was de-
livered to the cells in the presence of CQ at the indicated concen-
trations. After 24 hr PNA incubation, the cells were subjected to
RNA extraction and RT-PCR analysis as described in Figure 3B.
Analogous RT-PCR results were obtained with the Tat-PNA.7any significant cellular toxicity (data not shown), and
the finding was corroborated by RT-PCR data directly
showing mRNA splice correction (Figure 5B). Further-
more, CQ alone did not show significant effects on
RLUs without PNA addition. These results strongly indi-
cate that endosomal release of the PNA conjugates can
be induced by lysosomotrophic agents, and at least
part of the effect of Ca2+ may be due to a similar mech-
anism.
The effect of Ca2+ on endosomal escape was further
elucidated by using dextran (10 kDa) as a fluid-phase
marker (Figure 6). Cells were cotransfected with FITC-
labeled dextran and Alexa Fluor-labeled transferrin in
the absence or presence of 6 mM Ca2+ for 4 hr, and
then subjected to confocal microscopic studies after
further incubation (1 and 24 hr). Because we observed
that most of the green fluorescence from FITC-dextran
colocalized with the red fluorescence from the endocy-
totic marker transferrin (shown as yellow spots in the
merged picture) in the absence of Ca2+ treatment, we
conclude that most of the dextran was localized in
the endosomal compartment. In contrast, FITC-dextran
was localized both in the cytoplasm and endosome in
the Ca2+-treated cells after 1 hr incubation. Notably, no
significant release of transferrin was observed in these
experiments, most likely because of receptor binding of
this protein. The cytoplasmic distribution of the dextran
lasted even after the 24 hr incubation, whereas no such
cytoplasmic distribution is seen without Ca2+ treat-
ment. This cytoplasmic distribution of the dextran inFigure 6. Effect of Ca2+ Ions on the Intracellular Distribution of
Fluid-Phase Marker Dextran
Cells were transfected with FITC-labeled dextran (10 kDa, 2 mg/ml)
and Alexa Fluor 633-conjugated human transferrin (20 g/ml) for 4
hr in the absence or presence of 6 mM Ca2+ and subjected to con-
focal microscopic studies after 1 hr or 24 hr incubation in fresh
growth medium. Left, green fluorescent images from FITC-dextran;
center, red fluorescence images from the Alexa Fluor 633-conju-
gated dextran; right, superimposed images of green and red fluo-
rescent images. Each scale bar indicates 63 m.
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928the Ca2+-treated cells very strongly supports the con-
tention that Ca2+ treatment induces endosomal escape
of molecules such as PNA and dextran.
The calcium concentrations needed for optimal effect
are much higher than physiological concentrations
(micromolar range); therefore, the present findings are
hardly relevant for in vivo delivery and bioavailability of
cationic peptides and conjugates. However, they dem-
onstrate that agents that trigger endosomal release
should be of great interest. We also believe that our
findings are generally applicable to most or all agents
that are intrinsically cationic, such as lysine or arginine
backbone-modified PNAs [24–27], cationic peptides [7,
10, 11, 13, 23], proteins [17], or polyamines.
Significance
The present study clearly shows that low millimolar
concentrations of Ca2+ significantly enhance the nuclear
antisense effects of PNA oligomers conjugated to oli-
goarginine or to Tat peptide. The detailed mechanism
of the Ca2+ enhancement is not clear, but the data
strongly indicate that both increased membrane as-
sociation and, probably more importantly, increased
endosomal release of the PNA are involved. In direct
support of the latter mechanism, dextran (as a fluid-
phase marker) is released from endosomes by Ca2+.
It is particularly noteworthy that the Tat conjugate is
as active as the Arg7 conjugate in the presence of
Ca2+ despite the fact that it is much less active in the
absence of Ca2+. This finding would indicate that the
mechanism(s) of cellular uptake of Tat and oligoar-
ginine peptides differ in some aspect(s), which most
likely include higher (spontaneous) endosomal es-
cape of the oligoarginines. Although our results do
only reflect PNA activity in the nucleus, the nuclear
membrane would not be expected to be a major bar-
rier for PNA-peptide conjugates; analogous experi-
ments analyzing the cytoplasmatic effect of the PNAs
as well as the effect of Ca2+ on this are underway. As
we observe very little PNA in the nucleus (by confocal
microscopy), the data also suggest that, despite be-
ing taken up by the cell, a major part of the PNA is
trapped in a nonproductive compartment and that
significant improvement in biological efficacy should
be obtainable if more efficient enhancing compounds
than Ca2+ can be discovered, further improving the
potency of PNA. Clearly, these results are directly
relevant for delivery of other cationic PNA deriva-
tives, as well as for other (therapeutic) agents that
rely on endosomal escape for bioavailability. It would
be of particular interest if such compounds or re-
gimes would be applicable in vivo.
Experimental Procedures
Synthesis of PNAs
The sequences and nomenclature of the PNAs are listed in Table
1. PNA synthesis was carried out as reported previously [19]. The
PNAs were HPLC-purified and characterized by mass spectro-
metry. Cationic peptides were covalently linked to PNA at the
N-terminal through an ethyleneglycol linker (eg1, 8-amino-2,6-dioxa-
octanoic acid) or glycine via continuous synthesis. Fluorescein (Fl)-
labeled PNA oligomers were prepared using a previously described
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4fluorescein-lysine” monomer [20]. The PNAs were lyophilized and
tored at 4°C until use.
ell Culture
eLa pLuc705 cell line was purchased from GENE TOOLS (USA).
he cells were cultured in RPMI-1640 medium (Sigma) supple-
ented with 10% fetal bovine serum (FBS), 1.5% glutamax
GIBCO), and streptomycin/penicillin (100 U/ml each) at 37°C in hu-
idified air with 5% CO2. For the transfection studies in 96-well
late format, cells were trypsinized and seeded (1.2 × 104 cells/
ell) 16 hr before transfection. For the 24-well plate, 7.2 × 104 cells/
ell were used.
NA Transfection
eLa pLuc705 cells, replated in 96-well plates 16 hr earlier, were
reated with 100 l/well of OPTI-MEM (GIBCO) containing the PNA
t the desired concentration. For the Ca2+ or CQ supplementation
tudies, CaCl2 or CQ was added to the OPTI-MEM at the desired
oncentration. After 4 hr incubation, the cells were supplemented
ith 100 l/well of the growth medium (RPMI-1640 containing 10%
BS and 1.5% glutamax) and incubated further for 20 hr. For the
ransfection in 24-well plate format, 0.25 ml/well of OPTI-MEM and
rowth medium were used.
uciferase Assay
t 24 hr after PNA treatment, the cells in the 96-well plate were
ubjected to luciferase activity measurements. Luciferase activity
as measured with Fluoroskan Ascent FL (Labsystems) by using
he Bright-Glo Luciferase assay system (Promega). Measurements
ere performed according to the manufacturers’ instructions. Lu-
inescent readings (with background subtracted) are presented
s RLUs.
ytotoxicity Test
t 24 hr after PNA treatment, the cells in the 96-well plate were
ubjected to the cell viability test. Cell viabilities were determined
y using the CellTiter 96 Aqueous Non-Radioactive Cell Prolifera-
ion Assay (Promega) according to the manufacturer’s instructions.
he absorbance of treated cells was normalized to the absorbance
f untreated cells (the value of the control was counted as 100%)
nd is presented as relative cellular viability.
onfocal Microscopy
xponentially growing cells were plated in a 4-well Lab-Tek cham-
ered coverglass (Nunc) the day before transfection. For the PNA
ransfection studies, cells were incubated with OPTI-MEM medium,
ncluding 1 M of (Arg)7-Fl-PNA and 20 g/ml Alexa Fluor 633-
onjugated human transferrin (80 kDa, Molecular Probes) with or
ithout addition of 6 mM Ca2+. After 15 min, the cells were washed
nd incubated further for 45 min in a fresh OPTI-MEM medium, and
hen analyzed using a MultiProbe 2001 Laser Scanning Confocal
ystem equipped with an argon laser and a red laser diode (excita-
ion and absorbance wavelengths, 488 nm and 638 nm, respec-
ively; Radiance2000, BioRad) connected to a Nikon Eclipse TE200
icroscope (oil immersion 60× 1.4 NA objective; Nikon, Tokyo, Ja-
an). The Lasersharp 2000 software package (BioRad) was used
or image acquisition and processing.
For the dextran uptake studies, cells were incubated with OPTI-
EM, including 2 mg/ml of FITC-labeled dextran (10 kDa, Sigma)
nd 20 g/ml of Alexa Fluor 633-conjugated human transferrin in
he absence or presence of 6 mM Ca2+ for 4 hr. Cells were then
ncubated further in fresh growth medium for 1 or 24 hr and sub-
ected to confocal microscopy analysis as described above.
low Cytometry
eLa pLuc705 cells were plated in 24-wells plates the day before
he experiment. Immediately prior to transfection, cells were
ashed once with PBS and treated with 1 M of (Arg)7-Fl-PNA in
PTI-MEM in the presence or absence of 6 mM Ca2+. For the flow
ytometry analysis, cells were collected by scraping (Trypsin−) or
y trypsination (Trypsin+). For the scraping method, cells from one
ell were collected by scraping and subjected to the analysis in
00 l PBS. For trypsination, cells were washed with PBS three
Ca Enhancement of Antisense PNA-Peptide Conjugates
929times and trypsinized for 6 min at 37°C followed by the addition of
300 l growth medium. Cells were then washed once and sub-
jected to the analysis in 400 l PBS. Cells (2000 events) were ana-
lyzed using a BD FACSCalibur cytometer, and the mean fluores-
cence signal was sampled by CellQuest software. The fluorescence
index was calculated by dividing the mean fluorescence of the
PNA-treated sample by the mean fluorescence of a control sample
(without PNA treatment).
RT-PCR
Exponentially growing cells were cultured in 24-well plates the day
before treatment. Treatment with PNA was performed as described
above. After 24 hr, total RNA was extracted from the cells by using
RNeasy Mini kit (Qiagen) and subjected to RT-PCR. RT-PCR was
performed using OneStep RT-PCR kit (Qiagen). A total of 3 ng RNA
was used for each RT-PCR reaction (20 l). Primers for the RT-PCR
were as follows: forward primer, 5#-TTGATATGTGGATTTCGAGTC
GTC-3#; reverse primer, 5#-TGTCAAT-CAGAGTGCTTTTGGCG-3#.
The RT-PCR program was as follows: ([55°C, 35 min] × 1 cycle;
[95°C, 15 min] × 1 cycle; [94°C, 0.5 min; 55°C, 0.5 min; 72°C, 0.5
min] × 30 cycles). RT-PCR products were analyzed on 2% agarose
gel with 1× TBE buffer and visualized by ethidium bromide staining.
Gel images were captured by ImageMaster (Pharmacia Biotech)
and analyzed by UN-SCAN-IT software (Silk Scientific Corporation).
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